Insider Selling: Axon Enterprise (NASDAQ:AXON) Director Sells 629 Shares of Stock

Axon Enterprise, Inc (NASDAQ:AXON) Director Jeri Williams sold 629 shares of the business’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $469.64, for a total transaction of $295,403.56. Following the completion of the sale, the director directly owned 1,141 shares of the company’s stock, valued at $535,859.24. This represents a 35.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jeri Williams also recently made the following trade(s):

• On Tuesday, March 17th, Jeri Williams sold 157 shares of Axon Enterprise stock. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00.

Axon Enterprise Trading Up 2.8%

Axon Enterprise stock traded up $13.24 during mid-day trading on Tuesday, hitting $490.12. The company’s stock had a trading volume of 1,280,466 shares, compared to its average volume of 1,090,685. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. The stock has a market cap of $39.50 billion, a price-to-earnings ratio of 196.84, a price-to-earnings-growth ratio of 8.16 and a beta of 1.44. The business has a 50 day moving average price of $407.02 and a 200-day moving average price of $493.35. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.47 earnings per share. As a group, analysts forecast that Axon Enterprise, Inc will post 1.82 EPS for the current year.

Hedge Funds Weigh In On Axon Enterprise

Hedge funds and other institutional investors have recently modified their holdings of the stock. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise during the fourth quarter valued at about $28,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise during the third quarter valued at about $29,000. Sound Income Strategies LLC increased its position in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after buying an additional 44 shares during the period. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise during the fourth quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC purchased a new position in shares of Axon Enterprise during the fourth quarter valued at about $34,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. TD Cowen lowered their price objective on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. Citizens Jmp lowered their price objective on shares of Axon Enterprise from $825.00 to $700.00 and set a “market outperform” rating for the company in a research note on Thursday, May 7th. The Goldman Sachs Group set a $535.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. Barclays lowered their price objective on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research note on Friday, May 8th. Finally, Citigroup reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $712.75.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.